Lockheed Martin is looking to buy some of Vector’s assets after the Kanematsu-backed microsatellite launch services provider filed for bankruptcy.
Month: December 2019
Vanada veers from CyberAgent to Kinesys
Indonesia-based CyberAgent Capital executive director Steven Vanada has departed from the unit after more than eight years for a managing partner role at investment firm Kinesys Group.
DuPont locks in OxyMem acquisition
Saudi Aramco has exited wastewater treatment system developer OxyMem, which has been bought by another corporate investor, DuPont.
HqO finds the right formula for financing
JLL Spark returned to reinvest in the business tenant engagement platform as part of a $34.3m series B round that boosted its overall funding to $53m.
Investors pump $25m into Velano Vascular
Velano Vascular has closed a $25m round following an extension that added to $10m provided by investors including Intermountain Healthcare in May.
Game.tv presses start with $25m
The AI-powered esports tournament platform developer raised the cash in an Intel Capital-led round after spinning off from BlueStacks.
Beike Zhaofang to bake up $1bn IPO
Lianjia’s Tencent-backed online brokerage spinoff, valued at $9.5bn as of July, is exploring an initial public offering that could take place next year.
A2A sees $78m fund on the horizon
A2A has formed a corporate venturing vehicle with $78m in funding, including a commitment from Polytechnic University of Milan’s Poli360 fund.
Domio hosts SoftBank in $50m series B
The managed apartment provider secured $100m in series B and debt financing in August, from investors including SoftBank Capital NY, it disclosed this week.
Norton bids au revoir to Abbott Ventures
Managing director Evan Norton has stepped down from Abbott Ventures after leading the unit’s investment initiatives for nearly a decade, moving to Accelmed.
Sigstr reaches Terminus
HubSpot has exited email marketing platform developer Sigstr in an acquisition of undisclosed size by Terminus.
Iqvia lands on BC Platforms in $15m round
MIT-founded genomic data analytics spinout BC Platforms raised the cash in a series C round led by newly minted strategic partner Iqvia.
Promethera protracts series D round
Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug developer’s latest round to $52.6m.
Alchemy conjures up $15m
Samsung and Coinbase were among the investors that put up a total of $15m for Alchemy, which the blockchain protocol developer revealed when it emerged from stealth.